Kosj Yamoah MD, PhD

What an incredible day celebrating the ribbon-cutting at the @MoffittNews Speros Outpatient Center. I’m thrilled to showcase our Richard M. Schulze Family Foundation Proton Therapy Center, which will bring highly precise proton therapy to patients and expand access to care!

Day 2 of #MoffittROC26 is underway! Today’s sessions explore genomic radiation planning, radiomic-guided therapy, virtual reality, multidisciplinary tumor board collaboration, patient safety and the evolving science shaping modern radiation oncology.

Incredible lessons from keynote speaker Dr Harrison @MoffittNews

Kicking off Day 2 of the #Moffitt Radiation Oncology Conference with Dr Yamoah @KOSJ12 @MoffittNews @MoffittRadOnc

Enjoying some resident bonding while learning about surface guidance and kV triggered imaging at the 2026 @MoffittNews Radiation Oncology Conference! #radonc

Exciting things to come at #MoffittROC26! Stay tuned for the latest advances in radiation oncology from Moffitt experts.

Happening now at #MoffittROC26 Kujtim Latifi, PhD (@latifi_kuj8402), and Drew Lee, RT(T), discuss MRI-guided adaptive radiation therapy with MR-LINAC, using case-based examples to highlight its advantages for moving targets and the evolving clinical workflow and workforce required to support advanced imaging.

During #MoffittROC26, Gage Redler, PhD, and Lou Nardella, MS, discuss triggered imaging for intrafraction motion management in prostate and spine SBRT. Highlighting clinical cases and how advances in technology are reshaping treatment delivery and improving patient outcomes.

During the first session of #MoffittROC26, Daniel Opp, PhD, and Amber Nelsen, RT(T), present on clinical experience with surface-guided radiation therapy, highlighting its role in precision treatment delivery and outcomes in a variety of cancer types.

Kicking off the inaugural Moffitt Radiation Oncology conference with @PatrickHwuMD. Over the next few days, we’ll explore the future of radiation therapy, from proton therapy to next-generation technologies, advancing precision and improving patient outcomes. #MoffittROC26

Happening now at #MoffittROC26 Kosj Yamoah, MD, PhD, (@KOSJ12) and Patrick Hwu, MD ( @PatrickHwuMD) open Moffitt’s first Radiation Oncology Conference, highlighting a bold vision for the future of radiation therapy driven by innovation, research and next-generation technologies to improve patient outcomes.

At @MoffittNews, our mission is grounded in one principle: every patient deserves care built around them. Today, on #WorldCancerDay, we recognize that while each cancer journey is unique, we are stronger when we work together to advance personalized care, expand access, and improve outcomes for all. This year’s theme, United by Unique, reflects that commitment. #WorldCancerDay #UnitedByUnique #CancerCare #EndCancer

Starting next week, we’ll welcome the first patients to the Moffitt Speros Outpatient Center! At our Grand Opening, Marty Lanahan, Chair of the Speros Board of Directors, shared the bold vision behind the campus. Since breaking ground in January 2023, Speros has taken shape as a place where care, research and innovation come together. The first phase, expected to be completed by 2028, includes the outpatient and proton therapy center, the Moffitt Discovery & Innovation Center, new infrastructure, and a growing ecosystem of partners. Read more about what’s ahead at Speros: bit.ly/3YvHl2T

Proper nutrition plays a vital role in supporting cancer patients and survivors, while also helping reduce the risk of cancer. @MoffittNews' nutrition researcher @DrSylviaCrowder shares recipes packed with nutrient-rich, cancer-fighting foods. 🎥 Watch and get inspired to cook (and snack) your way to health: youtube.com/playlist?list=…

Join us as we celebrate the grand opening of the Moffitt Speros Outpatient Center! The state-of-the-art facility anchors the first phase of 775-acre Speros campus and brings proton therapy to Pasco County. Read more: bit.ly/3YvHl2T

Data from the prospective #VANDAAM study suggest that the Decipher Genomic Classifier strongly predicts 2-year biochemical recurrence in early localized prostate cancer, particularly among African American men. @KOSJ12 @MoffittNews urologytimes.com/view/study-val…

Join leading experts as we explore breakthroughs in radiotherapy! Don't miss the opportunity to connect with thought leaders, engage in multidisciplinary discussions and be part of the innovations shaping tomorrow’s standards in radiation oncology. Learn more and register now: bit.ly/4pvppjT #RadOnc

Tune in live for the Speros Grand Opening ceremony happening at 10:00 a.m. Watch live: speros.org